Protective role of somatostatin receptor 2 against retinal degeneration in response to hypoxia

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 385, Issue 5, 2012, Pages 481-494

  Monte, Massimo Dal ^a   Latina, Valentina ^a   Cupisti, Elena ^a   Bagnoli, Paola ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Bax Bcl 2 ratio; Caspase 3; ERG responses; Knockout mice; Oxygen induced retinopathy; Retinal explants

Indexed keywords

ANGIOGENESIS INHIBITOR; CASPASE 3; OCTREOTIDE; PROTEIN BAX; PROTEIN BCL 2; SOMATOSTATIN INHIBITING FACTOR RECEPTOR 2 AGONIST; SOMATOSTATIN RECEPTOR 2; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAPHY; ENZYME ACTIVITY; HYPOXIA; KNOCKOUT MOUSE; LIGHT EXPOSURE; MOUSE; NEUROPROTECTION; NONHUMAN; OSCILLATORY POTENTIAL; RETINA DEGENERATION; RETROLENTAL FIBROPLASIA; WILD TYPE;

ANGIOGENESIS INHIBITORS; ANIMALS; ANOXIA; APOPTOSIS; CASPASE 3; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OCTREOTIDE; OXYGEN; RECEPTORS, SOMATOSTATIN; RETINAL DEGENERATION;

EID: 84862876019     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-012-0735-1     Document Type: Article

References (92)

1. Akkoyun I, Karabay G, Haberal N, Dagdeviren A, Yilmaz G, Oto S, Erkanli L, Akova YA (2010) Structural consequences after intra-vitreal bevacizumab injection without increasing apoptotic cell death in a retinopathy of prematurity mouse model. Acta Oph-thalmol. doi:10.1111/j.1755-3768.2010.01963.x
2. Akopian A, Johnson J, Gabriel R, Brecha N, Witkovsky P (2000) Somatostatin modulates voltage-gated K(+) and Ca(2+) currents in rod and cone photoreceptors of the salamander retina. J Neurosci 20:929-936 (Pubitemid 30220449)
3. Akula JD, Hansen RM, Martinez-Perez ME, Fulton AB (2007a) Rod photoreceptor function predicts blood vessel abnormality in reti-nopathy ofprematurity. Invest Ophthalmol Vis Sci 48:4351-4359 (Pubitemid 351261069)
4. Akula JD, Mocko JA, Moskowitz A, Hansen RM, Fulton AB (2007b) The oscillatory potentials of the dark-adapted electroretinogram in retinopathy ofprematurity. Invest Ophthalmol Vis Sci 48:5788-5797 (Pubitemid 351260885)
5. Akula JD, Mocko JA, Benador IY, Hansen RM, Favazza TL, Vyhovsky TC, Fulton AB (2008) The neurovascular relation in oxygen-inducedretinopathy Mol Vis 14:2499-2508
6. Akula JD, Favazza TL, Mocko JA, Benador IY, Asturias AL, Kleinman MS, Hansen RM, Fulton AB (2010) The anatomy of the rat eye with oxygen- inducedretinopathy Doc Ophthalmol 120:41-50
7. Allen JP, Hathway GJ, Clarke NJ, Jowett MI, Topps S, Kendrick KM, Humphrey PP, Wilkinson LS, Emson PC (2003) Somatostatin receptor 2 knockout/lacZ knockin mice show impaired motor coordination and reveal sites of somatostatin action within the striatum. Eur J Neurosci 17:1881-1895 (Pubitemid 36645338)
8. Baldysiak-Figiel A, Lang GK, Kampmeier J, Lang GE (2004) Octreotide prevents growth factor-induced proliferation ofbovine retinal endo-thelial cells under hypoxia. J Endocrinol 180:417-424 (Pubitemid 38443394)
9. Block F, Schwarz M (1998) The b-wave of the electroretinogram as an index ofretinal ischemia. Gen Pharmacol 30:281-287 (Pubitemid 28046496)
10. Boehm BO (2007) Use oflong-acting somatostatin analogue treatment in diabetic retinopathy. Dev Ophthalmol 39:111-1217
11. Bresnick GH, Palta M (1987) Oscillatory potential amplitudes. Relation to severity ofdiabetic retinopathy Arch Ophthalmo 105:929-933 (Pubitemid 17092622)
12. Cammalleri M, Cervia D, Langenegger D, Liu Y, Dal Monte M, Hoyer D, Bagnoli P (2004) Somatostatin receptors differentially affect spontaneous epileptiform activity in mouse hippocampal slices. Eur J Neurosci 20:2711-2721 (Pubitemid 39573786)
13. Casini G, Dal Monte M, Petrucci C, Gambellini G, Grouselle D, Allen JP, Kreienkamp HJ, Richter D, Epelbaum J, Bagnoli P (2004) Altered morphology of rod bipolar cell axonal terminals in the retinas ofmice carrying genetic deletion of somatostatin subtype receptor 1 or 2. Eur J Neurosci 19:43-54 (Pubitemid 38122070)
14. Casini G, Catalani E, Dal Monte M, Bagnoli P (2005) Functional aspects of the somatostatinergic system in the retina and the potential therapeutic role of somatostatin in retinal disease. Histol Histopathol 20:615-632 (Pubitemid 40468280)
15. Catalani E, Cervia D, Martini D, Bagnoli P, Simonetti E, Timperio AM, Casini G (2007) Changes in neuronal response to ischemia in retinas with genetic alterations of somatostatin receptor expression. Eur J Neurosci 25:1447-1459 (Pubitemid 46568781)
16. Cervia D, Zizzari P, Pavan B, Schuepbach E, Langenegger D, Hoyer D, Biondi C, Epelbaum J, Bagnoli P (2003) Biological activity of somatostatin receptors in GC rat tumour somatotrophs: evidence with sst1-sst5 receptor-selective nonpeptidyl agonists. Neuro-pharmacology 44:672-685 (Pubitemid 36369144)
17. Cervia D, Casini G, Bagnoli P (2008a) Physiology and pathology of somatostatin in the mammalian retina: a current view. Mol Cell Endocrinol 286:112-122
18. Cervia D, Martini D, Ristori C, Catalani E, Timperio AM, Bagnoli P, Casini G (2008b) Modulation of the neuronal response to ischaemia by somatostatin analogues in wild-type and knock-out mouse retinas. JNeurochem 106:2224-2235
19. Chen YN, Yamada H, Mao W, Matsuyama S, Aihara M, Araie M (2007) Hypoxia-induced retinal ganglion cell death and the neuro-protective effects of beta-adrenergic antagonists. Brain Res 1148:28-37 (Pubitemid 46602166)
20. Cristiani R, Petrucci C, Dal Monte M, Bagnoli P (2002) Somatostatin (SRIF) and SRIFreceptors inthemouseretina. BrainRes 936:1-14
21. Dal Monte M, Petrucci C, Vasilaki A, Cervia D, Grouselle D, Epel-baum J, Kreienkamp HJ, Richter D, Hoyer D, Bagnoli P (2003a) Genetic deletion of somatostatin receptor 1 alters somatostatinergic transmission in the mouse retina. Neuropharmacology 45:1080-1092 (Pubitemid 37412253)
22. Dal Monte M, Petrucci C, Cozzi A, Allen JP, Bagnoli P (2003b) Somatostatin inhibits potassium-evoked glutamate release by ac-tivation of the sst(2) somatostatin receptor in the mouse retina. Naunyn Schmiedebergs Arch Pharmacol 367:188-192 (Pubitemid 36286879)
23. Dal Monte M, Cammalleri M, Martini D, Casini G, Bagnoli P (2007) Antiangiogenic role of somatostatin receptor 2 in a model of hypoxia-induced neovascularization in the retina: results from transgenic mice. Invest Ophthalmol Vis Sci 48:3480-3489 (Pubitemid 351261081)
24. Dal Monte M, Ristori C, Cammalleri M, Bagnoli P (2009) Effects of somatostatin analogues on retinal angiogenesis in a mouse model of oxygen-induced retinopathy: involvement of the somatostatin receptor subtype 2. Invest Ophthalmol Vis Sci 50:3596-3606
25. Dal Monte M, Ristori C, Videau C, Loudes C, Martini D, Casini G, Epelbaum J, Bagnoli P (2010) Expression, localization, and func-tional coupling of the somatostatin receptor subtype 2 in a mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 51:1848-1856
26. David J, Melamud A, Kesner L, Roth S, Rosenbaum PS, Barone FC, Popp S, Hassen GW, Stracher A, Rosenbaum DM (201 1)A novel calpain inhibitor for treatment of transient retinal ischemia in the rat Neuroreport 22:633-636
27. DeNiro M, Alsmadi O, Al-Mohanna F (2009) Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis. Exp Eye Res 89:700-717
28. Dorfman AL, Dembinska O, Chemtob S, Lachapelle P (2006) Structural and functional consequences of trolox C treatment in the rat model of postnatal hyperoxia. InvestOphthalmol Vis Sci47:1101-1108 (Pubitemid 46768345)
29. Dorfman AL, Cuenca N, Pinilla I, Chemtob S, Lachapelle P (2011) Immunohistochemical evidence of synaptic retraction, cytoarchi-tectural remodeling, and cell death in the inner retina of the rat model of oygen-induced retinopathy (OIR). Invest Ophthalmol Vis Sci 52:1693-1708
30. Downie LE, Pianta MJ, Vingrys AJ, Wilkinson-Berka JL, Fletcher EL (2007) Neuronal and glial cell changes are determined by retinal vascularization in retinopathy of prematurity. J Comp Neurol 504:404-417 (Pubitemid 47437203)
31. Downie LE, Hatzopoulos KM, Pianta MJ, Vingrys AJ, Wilkinson-Berka JL, Kalloniatis M, Fletcher EL (2010) Angiotensin type-1 receptor inhibition is neuroprotective to amacrine cells in a rat model ofretinopathy ofprematurity. J Comp Neurol 518:41-63
32. Du ZJ, Yamamoto T, Ueda T, Suzuki M, Tano Y, Kamei M (2011) Activated protein C rescues the retina from ischemia-induced cell death. Invest Ophthalmol Vis Sci 52:987-993
33. Englund-Johansson U, Mohlin C, Liljekvist-Soltic I (2010) Human neural progenitor cells promote photoreceptor survival in retinal explants. Exp Eye Res 90:292-299
34. Froidevaux S, Hintermann E, Török M, Mäcke HR, Beglinger C, Eberle AN (1999) Differential regulation of somatostatin receptor type 2 (sst 2) expression in AR4-2J tumor cells implanted into mice during octreotide treatment. Cancer Res 59:3652-3657 (Pubitemid 29381868)
35. Fulton AB, Reynaud X, Hansen RM, Lemere CA, Parker C, Williams TP (1999) Rod photoreceptors in infant rats with a history of oxygen exposure. Invest Ophthalmol Vis Sci 40:168-174 (Pubitemid 29029585)
36. Fulton AB, Hansen RM, Moskowitz A, Akula JD (2009) The neuro- vascular retina in retinopathy of prematurity. Prog Retin Eye Res 28:452-482
37. Gingrich JA, Hen R (2000) The broken mouse: the role ofdevelopment, plasticity and environment in the interpretation of phenotypic changes in knockout mice. Curr Opin Neurobiol 10:146-152 (Pubitemid 30102868)
38. Gong Y, Qiu Y, Song Z, Gu Q, Wu X, Sun X (2011) Effects of single intravitreal rhEPO injection on light-induced retinal injury in rats. Curr Eye Res 36:739-746
39. Guerin MB, Donovan M, McKernan DP, O'Brien CJ, Cotter TG (2011) Age-dependent rat retinal ganglion cell susceptibility to apoptotic stimuli: implications for glaucoma. Clin Exp Ophthalmol 39:243-251
40. Heidary G, Vanderveen D, Smith LE (2009) Retinopathy ofprematurity: current concepts in molecular pathogenesis. Semin Ophthalmol 24:77-81
41. Higgins RD, Yan Y, Schrier BK (2002) Somatostatin analogs inhibit neonatal retinal neovascularization. Exp Eye Res 74:553-559 (Pubitemid 34757010)
42. Janaky M, Grosz A, Toth E, Benedek K, Benedek G (2007) Hypobaric hypoxia reduces the amplitude of oscillatory potentials in the human ERG. Doc Ophthalmol 114:45-51 (Pubitemid 46206515)
43. Johnson J, Rickman DW, Brecha NC (2000) Somatostatin and somato- statin subtype 2A expression in the mammalian retina. Microsc Res Tech 50:103-111 (Pubitemid 30491055)
44. Johnson J, Caravelli ML, Brecha NC (2001) Somatostatin inhibits calcium influx into rat rod bipolar cell axonal terminals. Vis Neurosci 18:101-108 (Pubitemid 32319012)
45. Kaempf S, Walter P, Salz AK, Thumann G (2008) Novel organotypic culture model of adult mammalian neurosensory retina in co- culture with retinal pigment epithelium. J Neurosci Methods 173:47-58
46. Katai N, Yoshimura N (1999) Apoptotic retinal neuronal death by ischemia-reperfusion is executed by two distinct caspase family proteases. Invest Ophthalmol Vis Sci 40:2697-2705 (Pubitemid 29455502)
47. Kaur C, Foulds WS, Ling EA (2008) Hypoxia-ischemia and retinal ganglion cell damage. Clin Ophthalmol 2:879-889
48. Ke JB, Zhong YM (2007) Expression of somatostatin receptor subtype 5 in rat retinal amacrine cells. Neuroscience 144:1025-1032
49. Kiagiadaki F, Thermos K (2008) Effect ofintravitreal administration of somatostatin and sst2 analogs on AMPA-induced neurotoxicity in rat retina. Invest Ophthalmol Vis Sci 49:3080-3089
50. Kiagiadaki F, Savvaki M, Thermos K (2010) Activation of somatostatin receptor (sst 5) protects the rat retina from AMPA-induced neuro- toxicity Neuropharmacology 58:297-303
51. Ko ML, Chen CF, Peng PH, Peng YH (2011) Simvastatin upregulates Bcl-2 expression and protects retinal neurons from early ischemia/ reperfusion injury in the rat retina. Exp Eye Res 93:580-585
52. Kojima H, Otani A, Oishi A, Makiyama Y, Nakagawa S, Yoshiumra N (2011) Granulocyte colony-stimulating factor attenuates oxidative stress-induced apoptosis in vascular endothelial cells and exhibits functional and morphologic protective effect in oxygen-induced retinopathy Blood 117:1091-1100
53. Kramerov AA, Saghizadeh M, Caballero S, Shaw LC, Li Calzi S, Bretner M, Montenarh M, Pinna LA, Grant MB, Ljubimov AV (2008) Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites. Mol Cell Biochem 316:177-186
54. Kreienkamp HJ, Akgün E, Baumeister H, MeyerhofW, Richter D (1999) Somatostatin receptor subtype 1 modulates basal inhibition of growth hormone release in somatotrophs. FEBS Lett 462:464-466
55. Lachapelle P, Dembinska O, Rojas LM, Benoit J, Almazan G, Chemtob S (1999) Persistent functional and structural retinal anomalies in new- born rats exposed to hyperoxia. Can J Physiol Pharmacol 77:48-55 (Pubitemid 29297357)
56. Liu K, Akula JD, Falk C, Hansen RM, Fulton AB (2006a) The retinal vasculature and function of the neural retina in a rat model of retinopathy ofprematurity. Invest Ophthalmol Vis Sci 47:2639-2647 (Pubitemid 351639852)
57. Liu K, Akula JD, Hansen RM, Moskowitz A, Kleinman MS, Fulton AB (2006b) Development of the electroretinographic oscillatory potentials in normal and ROP rats. Invest Ophthalmol Vis Sci 47:5447-5452 (Pubitemid 46723796)
58. Mali RS, Cheng M, Chintala SK (2005) Intravitreous injection of a membrane depolarization agent causes retinal degeneration viamatrix metalloproteinase-9. Invest Ophthalmol Vis Sci 46:2125-2132
59. Martini D, Dal Monte M, Ristori C, Cupisti E, Mei S, Fiorini P, Filippi L, Bagnoli P (2011) Antiangiogenic effects of ß(2) -adrenergic receptor blockade in a mouse model of oxygen-induced retinop-athy. JNeurochem 119:1317-1329
60. McKernan DP, Caplis C, Donovan M, O'Brien CJ, Cotter TG (2006) Age-dependent susceptibility of the retinal ganglion cell layer to cell death. Invest Ophthalmol Vis Sci 47:807-814 (Pubitemid 46768310)
61. Mei S, Cammalleri M, Azara D, Casini G, Bagnoli P, Dal Monte M (2011) Mechanisms underlying somatostatin receptor 2 downregu-lation of vascular endothelial growth factor expression in response to hypoxia in mouse retinal explants. J Pathol 226:519-533
62. Moneta D, Richichi C, Aliprandi M, Dournaud P, Dutar P, Billard JM, Carlo AS, Viollet C, Hannon JP, Fehlmann D, Nunn C, Hoyer D, Epelbaum J, Vezzani A (2002) Somatostatin receptor subtypes 2 and 4 affect seizure susceptibility and hippocampal excitatory neurotransmission in mice. Eur J Neurosci 16:843-849 (Pubitemid 35463576)
63. Naka KI, Rushton WA (1966) S-potentials from luminosity units in the retina offish (Cyprinidae). J Physiol 185:587-599
64. Narayanan SP, Suwanpradid J, Saul A, Xu Z, Still A, Caldwell RW, Caldwell RB (2011) Arginase 2 deletion reduces neuro-glial in-jury and improves retinal function in a model of retinopathy of prematurity PLoS One 6:e22460
65. Nickells RW, Semaan SJ, Schlamp CL (2008) Involvement of the Bcl2 gene family in the signaling and control of retinal ganglion cell death. Prog Brain Res 173:423-435
66. Oshitari T, Yoshida-Hata N, Yamamoto S (2010) Effect ofneurotrophic factors on neuronal apoptosis and neurite regeneration in cultured rat retinas exposed to high glucose. Brain Res 1346:43-51
67. Palii SS, Caballero S Jr, Shapiro G, Grant MB (2007) Medical treatment of diabetic retinopathy with somatostatin analogues. Expert Opin Investig Drugs 16:73-82 (Pubitemid 44964168)
68. Park YJ, Kim YH, Chung IY, Yoo JM (2010) Treatment with triamcin-olone acetonide prevents decreased retinal levels of decorin in a rat model ofoxygen-induced retinopathy Curr Eye Res 35:657-663
69. Pavan B, Fiorini S, Dal Monte M, Lunghi L, Biondi C, Bagnoli P, Cervia D (2004) Somatostatin coupling to adenylyl cyclase activ-ity in the mouse retina. Naunyn Schmiedebergs Arch Pharmacol 370:91-98 (Pubitemid 39222860)
70. Péquignot MO, Provost AC, Salle S, Taupin P, Sainton KM, Marchant D, Martinou JC, Ameisen JC, Jais JP, Abitbol M (2003) Major role of BAX in apoptosis during retinal development and in establishment ofafunctional postnatal retina. Dev Dyn 228:231-238 (Pubitemid 37193635)
71. Petrucci C, Resta V, Fieni F, Bigiani A, Bagnoli P (2001) Modulation of potassium current and calcium influx by somatostatin in rod bipolar cells isolated from the rabbit retina via sst2 receptors. Naunyn Schmiedebergs Arch Pharmacol 363:680-694 (Pubitemid 32477276)
72. Pfeiffer M, Koch T, Schroder H, Klutzny M, Kirscht S, Kreienkamp HJ, Hollt V Schulz S (2001) Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A). J Biol Chem 276:14027-14036
73. Produit-Zengaffinen N, Pournaras CJ, Schorderet DF (2009) Retinal ischemia-induced apoptosis is associated with alteration in Bax and Bcl-x(L) expression rather than modifications in Bak and Bcl-2. Mol Vis 15:2101-2110
74. Qiu W, Wei R, Zhang C, Zhang C, Leng W, Wang W (2010) A glycine site-specific NMDA receptor antagonist protects retina ganglion cells from ischemic injury by modulating apoptotic cascades. J Cell Physiol 223:819-826
75. Ristori C, Filippi L, Dal Monte M, Martini D, Cammalleri M, Fortunato P, la Marca G, Fiorini P, Bagnoli P (2011) Role of the adrenergic system in a mouse model ofoxygen-induced retinopathy: antiangio-genic effects of beta-adrenoreceptor blockade. Invest Ophthalmol Vis Sci 52:155-170
76. Rivera JC, Sapieha P, Joyal JS, Duhamel F, Shao Z, Sitaras N, Picard E, Zhou E, Lachapelle P, Chemtob S (2011) Understanding retinopathy ofprematurity: update on pathogenesis. Neonatology 100:343-353
77. Robson JG, Saszik SM, Ahmed J, Frishman LJ (2003) Rod and cone contributions to the a-wave of the electroretinogram of the macaque. J Physiol 547:509-530 (Pubitemid 36304984)
78. Rocheville M, Lange DC, Kumar U, Sasi R, Patel RC, Patel YC (2000) Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J Biol Chem 275:7862-7869 (Pubitemid 30159693)
79. Shah SM, Nguyen QD, Mir HS, Polito A, Hafiz G, Tatlipinar S, Do DV, Vitale S, Haller JA (2010) A randomized, double-masked controlled clinical trial of Sandostatin long-acting release depot in patients with postsurgical cystoid macular edema. Retina 30:160-166
80. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101-111 (Pubitemid 24046832)
81. Stevenson L, Matesanz N, Colhoun L, Edgar K, Devine A, Gardiner TA, McDonald DM (2010) Reduced nitro-oxidative stress and neural cell death suggests a protective role for microglial cells in TNFalpha-/- mice in ischemic retinopathy. Invest Ophthalmol Vis Sci 51:3291-3299
82. Tezel G, Wax MB (1999) Inhibition ofcaspase activity in retinal cell apoptosis induced by various stimuli in vitro. Invest Ophthalmol Vis Sci 40:2660-2667 (Pubitemid 29455497)
83. Valenciano AI, Boya P, De La Rosa EJ (2009) Early neural cell death: numbers and cues from the developing neuroretina. Int J Dev Biol 53:1515-1528
84. Vasilaki A, Thermos K (2009) Somatostatin analogues as therapeutics in retinal disease. Pharmacol Ther 122:324-333
85. Vessey KA, Wilkinson-Berka JL, Fletcher EL (2011) Characterization of retinal function and glial cell response in a mouse model of oxygen induced retinopathy. J Comp Neurol 519:506-527
86. Wachtmeister L (1981) Further studies of the chemical sensitivity of the oscillatory potentials of the electroretinogram (ERG). II. Glutamate- aspartate- and dopamine antagonists. Acta Ophthalmol 59:247-258 (Pubitemid 11106518)
87. Wachtmeister L (1983) The action of peptides on the mudpuppy electroretinogram (ERG). Exp Eye Res 37:429-437 (Pubitemid 14216085)
88. Wachtmeister L (1998) Oscillatory potentials in the retina: what do they reveal. Prog Retin Eye Res 17:485-521 (Pubitemid 28432979)
89. Wilkinson-Berka JL, Heine R, Tan G, Cooper ME, Hatzopoulos KM, Fletcher EL, Binger KJ, Campbell DJ, Miller AG (2010) RILLKKMPSV influences the vasculature, neurons and glia, and (pro)renin receptor expression in the retina. Hypertension 55:1454-1460
90. Young RW (1984) Cell death during differentiation of the retina in the mouse. J Comp Neurol 229:362-373 (Pubitemid 15201535)
91. Zalutsky RA, Miller RF (1990) The physiology of somatostatin in the rabbit retina. J Neurosci 10:383-393 (Pubitemid 20089061)
92. Zhang B, Safa R, Rusciano D, Osborne NN (2007) Epigallocatechin gallate, an active ingredient from green tea, attenuates damaging influences to the retina caused by ischemia/reperfusion. Brain Res 1159:40-53 (Pubitemid 47064392)